Alteba S, Mizrachi Zer-Aviv T, Tenenhaus A, Ben David G, Adelman J, Hillard C, Doron R, Akirav I (inn press) Antidepressant effects of URB597 and JZL14 in male and female rats exposed to early life stress, Eur neuropsychopharmacology
Doron R, Versano Z, Burstein O, Franko M, Shamir A, Toledano R, Handelsman A, Moshe R (2019) Cerebral MAO activity is not altered by a novel herbal antidepressant treatment. Journal of Molecular Neuroscience (IF2.29) Q1
Dabbah-Assadi F, Alon D, Golani I,Doron R ,Kremer I,Beloosesky R,.Shamir A (2019) The influence of immune activation at early vs late gestation on fetal NRG1-ErbB4 expression and behavior in juvenile and adult mice offspring. Brain Behavior and Immunity
Burstein O, Doron R. (2018) Assessment of Hedonic Tone Following the Unpredictable Chronic Mild Stress Mice Model for Depression. Journal of Visualized Experiments (JOVE)
Doron R, Sever A , Handelsman A, Toledano R, Franko M, Hirshler Y, Shamir A, Burstein O, Rehavi M (2018) GABAA Receptor Density is not Altered by a Novel Herbal Anxiolytic Treatment. Journal of Molecular Neuroscience
Burstein O, Shoshan N, Doron R* , Akirav I* (2018) Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD, Progress in Neuropsychopharmacology & Biological Psychiatry 84 ,129–139
[Equal contribution]
Sarne y, Toledano R, Rachmany L, Sasson E, Doron R (2018) Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol (THC), Neurobiology of Aging (IF 5.1) Q1 ,cit 1
Burstein O, Franko M, Gale E, HandelsmanA, Barak S, Motsan S , Shamir A, ToTledano R , Simhon O , Hirshler Y , Gang Chen G, Doron R (2017) Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression, PloS ONE 2(11):e0188043.
doi: 10.1371
Tadmor H, Golani I, Grozovski M, Doron R, Kremer I, Shamir A (2017) ErbB signaling antagonist ameliorate behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers, Progress in Neuro-Psychopharmacology and Biological Psychiatry
Hirshler Y, Doron R ( 2017) Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines, Eur neuropsychopharmacology
Avitsur R, Paley S, Franko M, Wolff N, Eyal N, Doron R (2017) Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge. J Neuroimmunol. 15;309:111-118
Wu, R. Tao, W. Zhang, H. Xue,w. Zou, Z. Wu,Baochang Cai,H. Doron,R. Chen, G. (2016) Instant and Persistent Antidepressant Response of Gardenia Yellow Pigment Is Associated with Acute Protein Synthesis and Delayed Up-Regulation of BDNF Expression in the Hippocampus. ACS Chemical Neuroscience
Xia B, Zhang H, Xue W, Tao W, Chen C, Wu R, Ren L, Tang J, Wu H, Cai B, Doron R, Chen G. (2016) Instant and Lasting Down-Regulation of NR1 Expression in the Hippocampus is Associated Temporally with Antidepressant Activity After Acute Yueju. Cell Mol Neurobiol 36(7):1189-96
Yankelevitch-YahavR , Franco M, Huly A, Doron R. (2015) The forced swim test as a model of depressive-like behavior. Journal of Visualized Experiments (JOVE), 2;(97) p.1-7
Doron R, Lotan D, Versano Z, Benatav L, Franko M, Armoza S, Kately N, Rehavi M (2014) Escitalopram or novel herbal mixture treatments during or following exposure to stress reduces anxiety-like behavior through corticosterone and BDNF modifications. PLoS ONE (4):e91455 p.1-9
Doron R, Lotan D, Einat N, Yaffe R, Winer A, Marom I, Meron G, Kately N, Rehavi M (2014). A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life science 17;94(2):151-7